<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04602988</url>
  </required_header>
  <id_info>
    <org_study_id>2020P000678</org_study_id>
    <nct_id>NCT04602988</nct_id>
  </id_info>
  <brief_title>Study to Assess and Monitor Brain Activity</brief_title>
  <acronym>SAMBA</acronym>
  <official_title>Continuous, Non-Invasive Monitoring of Mental Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A mainstay in the diagnosis and care of hospitalized patients is the assessment of mental&#xD;
      status. Changes in mental status can have broad clinical significance, and while some&#xD;
      patients are admitted with mental status changes, nearly half of the patients who experience&#xD;
      delirium in the hospital develop it after admission in a manner that is hard to predict on&#xD;
      the level of individual patients. Patients with altered mental status such as delirium have&#xD;
      worse clinical outcomes, suggesting that early monitoring of mental status can identify&#xD;
      important clinical populations who may benefit from targeted delirium prevention and&#xD;
      intervention. Delirium remains under-recognized in the hospital, in part due to its&#xD;
      fluctuating nature. Typically, mental status is assessed sporadically, perhaps once a day,&#xD;
      through intermittent and subjective clinical interactions. As such, there is a clear clinical&#xD;
      need for objective, continuous methods to monitor mental status. Such methods could&#xD;
      potentially improve detection of delirium, potentially even predicting it prior to clinical&#xD;
      recognition, and therefore direct multimodal delirium prevention and intervention strategies&#xD;
      when most effective-before delirium becomes fully manifest. In this proposal we plan on&#xD;
      testing noninvasive, continuous monitors of mental status in the inpatient setting, primarily&#xD;
      through the use of EEG.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 10, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Delirium Severity</measure>
    <time_frame>Daily during the time of EEG recording up to 7 days</time_frame>
    <description>Inpatient Delirium as assessed by the 3D-CAM-S</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EEG</measure>
    <time_frame>Daily during the time of EEG recording up to 7 days</time_frame>
    <description>Relative EEG power in the delta &amp; theta bands</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>3 months after completion of EEG recording</time_frame>
    <description>Functional status as assessed by the Glasgow Outcome Score (1-5, with lower numbers less favorable outcomes and higher numbers more favorable outcomes)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Delirium</condition>
  <condition>Encephalopathy</condition>
  <arm_group>
    <arm_group_label>Patients admitted to an inpatient hospital unit</arm_group_label>
    <description>Patients admitted to an inpatient hospital unit will receive EEG based monitoring of mental status</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>EEG monitoring of brain rhythms</description>
    <arm_group_label>Patients admitted to an inpatient hospital unit</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited after their admission to inpatient medical units at the&#xD;
        participating hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to a general medical ward&#xD;
&#xD;
          -  Expected stay of at least one night&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who have any scalp incisions or head wound(s) that would prevent EEG&#xD;
             attachment&#xD;
&#xD;
          -  Non-English speakers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eyal Y Kimchi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eyal Y Kimchi, MD, PhD</last_name>
    <phone>617-726-3311</phone>
    <email>ekimchi@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eyal Kimchi, MD, PhD</last_name>
      <phone>617-726-3311</phone>
      <email>ekimchi@partners.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 18, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Eyal Y. Kimchi, M.D.,Ph.D.</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>EEG</keyword>
  <keyword>Mental Status</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

